Appeals Court Revives Lawsuit Against FDA Over Ivermectin Messaging

Federal appeals court breathes new life into lawsuit against FDA over COVID-19 ivermectin campaign.

Pexels Ekaterina Bolovtsova 6077326
EKATERINA BOLOVTSOVA

According to a recent article from The Hill, federal appeals court has greenlit a lawsuit against the FDA over its stance on ivermectin as a COVID-19 treatment. Three doctors alleged that the FDA exceeded its authority by aggressively campaigning against the use of ivermectin for COVID-19, arguing that the agency acted more like a medical body than a regulator. The 5th Circuit Appeals Court ruled in favor of the doctors, stating that while the FDA can inform and apprise, it should not endorse, denounce, or advise on specific medical treatments. The FDA's campaign emphasized that ivermectin, an anti-parasitic medication used in both humans and animals, was not authorized for COVID-19 treatment. 

Fresh from the show floor: pharma packaging innovations for 2026
Serialization mandates. Containment demands. Sterile barrier requirements. Our editors found the pharma packaging innovations addressing your biggest challenges at PACK EXPO Las Vegas. Get your free curated report now.
GET YOUR COPY
Fresh from the show floor: pharma packaging innovations for 2026